Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02036086
Title	Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Recruitment	Unknown status
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Sunnybrook Health Sciences Centre
Indications	melanoma
Therapies	Cobimetinib + Vemurafenib
Age Groups:	adult \| senior
Covered Countries	CAN